National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 35656-35657 [2015-15165]
Download as PDF
<![CDATA[
35656
Federal Register / Vol. 80, No. 119 / Monday, June 22, 2015 / Notices
The meeting will be held on
Tuesday, July 21, 2015, from 8:30 a.m.
until 5:00 p.m. and Wednesday, July 22,
2015, from 8:30 a.m. until 4:30 p.m.
ADDRESSES: Fishers Lane Conference
Center, Terrace Level, 5635 Fishers
Lane, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Jerry
Menikoff, M.D., J.D., Director, Office for
Human Research Protections (OHRP), or
Julia Gorey, J.D., Executive Director,
SACHRP; U.S. Department of Health
and Human Services, 1101 Wootton
Parkway, Suite 200, Rockville,
Maryland 20852; 240–453–8141; fax:
240–453–6909; email address:
SACHRP@hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
authority of 42 U.S.C. 217a, Section 222
of the Public Health Service Act, as
amended, SACHRP was established to
provide expert advice and
recommendations to the Secretary of
Health and Human Services through the
Assistant Secretary for Health on issues
and topics pertaining to or associated
with the protection of human research
subjects.
The meeting will open to the public
at 8:30 a.m. on Tuesday, July 21, 2015.
Following opening remarks from Dr.
Jerry Menikoff, Executive Secretary of
SACHRP and OHRP Director, and Dr.
Jeffrey Botkin, SACHRP Chair, the
Subpart A Subcommittee (SAS) will
present their report on informed consent
for minimal risk research. SAS was
established by SACHRP in October 2006
and is charged with developing
recommendations for consideration by
SACHRP regarding the application of
subpart A of 45 CFR part 46 in the
current research environment.
In the afternoon of July 21, the
Subcommittee on Harmonization (SOH)
will present their report, including
recommendations pertaining to waiver
of consent in cluster randomized trials,
the application of the HHS regulations
to data registries, and the topic of
‘‘benchmarking’’ in human subjects
research. SOH was established by
SACHRP at its July 2009 meeting and is
charged with identifying and
prioritizing areas in which regulations
and/or guidelines for human subjects
research adopted by various agencies or
offices within HHS would benefit from
harmonization, consistency, clarity,
simplification and/or coordination. On
July 22, the SOH will discuss the return
of individual research results with
special considerations regarding HIPAA
and CLIA.
In the afternoon special guest speaker
Dr. Robert Klitzman will present on his
recent work, The Ethics Police. The
meeting will adjourn at 4:30 p.m. on
tkelley on DSK3SPTVN1PROD with NOTICES
DATES:
VerDate Sep<11>2014
17:45 Jun 19, 2015
Jkt 235001
July 22, 2015. Time for public comment
sessions will be allotted both days.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify one of
the designated SACHRP points of
contact at the address/phone number
listed above at least one week prior to
the meeting. Pre-registration is required
for participation in the on-site public
comment session; individuals may preregister the day of the meeting.
Individuals who would like to submit
written statements should email or fax
their comments to SACHRP at
SACHRP@hhs.gov at least five business
days prior to the meeting.
Dated: June 17, 2015.
Jerry Menikoff,
Executive Secretary, Secretary’s Advisory
Committee on Human Research Protections,
Director, Office for Human Research
Protections.
[FR Doc. 2015–15286 Filed 6–19–15; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel,
Developing Technologies and Tools to
Monitor HIV Brain Reservoirs and How They
May be Altered by Exposure to Substances of
Abuse (R21/R33).
Date: July 16, 2015.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Blvd., Room 4245,
Rockville, MD 20852, 301–435–1426,
mcguireso@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIDA I/
START Small Grant Review.
Date: July 21, 2015.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Jagadeesh S. Rao, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4234, MSC 9550, Bethesda, MD 02892, 301–
443–9511, jrao@nida.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: June 16, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–15168 Filed 6–19–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Planning Grants (R34) and NIAID Clinical
Trial Implementation Cooperative Agreement
(U01).
Date: July 17, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\22JNN1.SGM
22JNN1
Federal Register / Vol. 80, No. 119 / Monday, June 22, 2015 / Notices
Place: National Institutes of Health, 5601
Fisher Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: B. Duane Price, Ph.D.,
Scientific Review Officer, Scientific
Review Program,
Division of Extramural Activities, RM
3G50, National Institutes of Health, NIAID,
5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823,
240–669–5074,
pricebd@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIAID Clinical Trial
Planning Grant (R34) and Implementation
(R01) Grant and Cooperative Agreement
(U01).
Date: July 20, 2015.
Time: 10:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fisher Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Maryam Feili-Hariri,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 5601 Fishers Lane, Rockville, MD
20852, 240–669–5026, haririmf@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 16, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–15165 Filed 6–19–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
tkelley on DSK3SPTVN1PROD with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the National Advisory
Neurological Disorders and Stroke
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Sep<11>2014
17:45 Jun 19, 2015
Jkt 235001
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Neurological Disorders and Stroke Council.
Date: September 10–11, 2015.
Open: September 10, 2015, 8:00 a.m. to
3:00 p.m.
Agenda: Report by the Director, NINDS;
Report by the Associate Director for
Extramural Research; and Administrative and
Program Developments.
Place: National Institutes of Health,
Natcher Building, 45 Convent Drive,
Conference Room E1/E2, Bethesda, MD
20892.
Closed: September 10, 2015, 3:00 p.m. to
5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Convent Drive,
Conference Room E1/E2, Bethesda, MD
20892.
Closed: September 11, 2015, 8:00 a.m. to
11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Convent Drive,
Conference Room E1/E2, Bethesda, MD
20892.
Contact Person: Robert Finkelstein, Ph.D.,
Associate Director for Extramural Research,
National Institute of Neurological Disorders
and Stroke, NIH, 6001 Executive Blvd., Suite
3309, MSC 9531, Bethesda, MD 20892, (301)
496–9248.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninds.nih.gov, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
35657
Dated: June 16, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–15166 Filed 6–19–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; SBIR:
Development of Cancer Therapeutics.
Date: July 14–15, 2015.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Malaya Chatterjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, (301) 806–
2515, chatterm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Bacterial Pathogenesis.
Date: July 16–17, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Richard G Kostriken,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 240–519–
7808, kostrikr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; EB15–004:
Pediatric Research using Integrated Sensor
Monitoring Systems Data and Software
Coordination and Integration Centers (U24).
Date: July 22, 2015.
Time: 12:00 p.m. to 5:00 p.m.
E:\FR\FM\22JNN1.SGM
22JNN1
]]>Agencies
[Federal Register Volume 80, Number 119 (Monday, June 22, 2015)]
[Notices]
[Pages 35656-35657]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15165]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Clinical Trial Planning
Grants (R34) and NIAID Clinical Trial Implementation Cooperative
Agreement (U01).
Date: July 17, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 35657]]
Place: National Institutes of Health, 5601 Fisher Lane,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: B. Duane Price, Ph.D.,
Scientific Review Officer, Scientific Review Program,
Division of Extramural Activities, RM 3G50, National Institutes
of Health, NIAID,
5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892-9823,
240-669-5074,
pricebd@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, NIAID Clinical Trial Planning Grant
(R34) and Implementation (R01) Grant and Cooperative Agreement
(U01).
Date: July 20, 2015.
Time: 10:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fisher Lane,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 5601 Fishers Lane,
Rockville, MD 20852, 240-669-5026, haririmf@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: June 16, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-15165 Filed 6-19-15; 8:45 am]
BILLING CODE 4140-01-P
